- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- July 2024
- 145 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 88 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- September 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- April 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- March 2025
- 259 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- August 2024
- 141 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- September 2024
- 144 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- May 2024
- 187 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2024
- 211 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- June 2024
- 173 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- November 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP

Contract Manufacturing Organizations (CMOs) are companies that provide manufacturing services to the pharmaceutical industry. CMOs specialize in the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). They provide a range of services, from process development and scale-up to commercial manufacturing and packaging. CMOs are an important part of the pharmaceutical supply chain, as they enable drug companies to outsource production and focus on their core competencies.
CMOs are subject to stringent regulatory requirements, and must adhere to Good Manufacturing Practices (GMPs) to ensure the quality and safety of their products. They must also comply with the regulations of the countries in which they operate.
CMOs offer a range of advantages to drug companies, including cost savings, access to specialized expertise, and flexibility in production. They also provide a way for drug companies to quickly scale up production to meet demand.
Some of the leading CMOs in the pharmaceutical manufacturing market include Lonza, Boehringer Ingelheim, Patheon, and Recipharm. Show Less Read more